A plant-based fiber that feeds the good bacteria in your gut, XOS ensures that the probiotic strains in Bioma thrive and ...

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced it has ...

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is proud to announce the launch of its 2030 Strategic Plan, a forward-thinking roadmap designed to reinforce ...

A link to the live and archived webcast may be accessed on Opus Genetics’ website under the Investors section: Events.

Männedorf, Switzerland, August 5, 2025 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2025 on Tuesday, August 12th ...

IRB approval from Hadassah Medical Center follows Clearmind’s prior regulatory milestones, including U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug (IND) application ...

The webcast of the fireside chat will be accessible in the Investor section of the CervoMed website About CervoMed CervoMed is a clinical-stage company focused on developing treatments for ...

ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C. Theofilos has been ...

The Company’s pre-clinical data demonstrates CRB-913 is markedly more peripherally restricted than either monlunabant or rimonabant. CRB-913 has a brain to plasma ratio 50-times lower than rimonabant ...

Y-mAbs stockholders holding approximately 16% of Y-mAbs’ outstanding shares of common stock have entered into a tender and support agreement with SERB, pursuant to which such stockholders have agreed, ...

LAKEWOOD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, ...